These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3302387)

  • 1. [Antithrombin III and heparin].
    Ukita M
    Rinsho Byori; 1987 Apr; Spec No 70():173-80. PubMed ID: 3302387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of activity of antithrombin III - heparin in blood].
    Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1982; (4):232-4. PubMed ID: 6177911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients].
    Oguma Y; Hasegawa H; Nagata H; Kawakami Y
    Rinsho Ketsueki; 1986 May; 27(5):723-9. PubMed ID: 3747167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
    Sampol J; Rossi JM; Lejay G
    Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose heparin in elective abdominal surgery. Correlation between concentrations of heparin, antithrombin III and antiplasmin in patients with and without DVT.
    Kruse-Blinkenberg HO; Gormsen J; Jensen J; Thomsen F; Wille-Jørgensen P
    Acta Chir Scand; 1980; 146(6):383-90. PubMed ID: 7008476
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assays.
    Savidge GF; Kesteven PJ; Al-Hasani SF; O'Brien PF
    Thromb Haemost; 1983 Oct; 50(3):745-8. PubMed ID: 6648894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
    Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis].
    Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA
    Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
    Scully MF
    Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
    [No Abstract]   [Full Text] [Related]  

  • 13. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR; van Hoef B; Collen D
    Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W; Glöckner WM; Müller N
    Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombin III (clinical aspects and methodology)].
    Abildgaard U
    Ric Clin Lab; 1978; 8 Suppl 2():90-7. PubMed ID: 106453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood antithrombin III levels after prolonged administration of heparin].
    Soska V; Lupínek Z; Hrcková V; Parák T
    Vnitr Lek; 1988 May; 34(5):456-60. PubMed ID: 3414028
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.